Rein Therapeutics Inc.
XNAS: RNTX
Rein Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart
about
Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LT...
Read More
1.33
-0.03
(-2.21%)
90,842
XNAS Volume
High vol.+gain this week
XNAS 05 Sep, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Rein Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..